Literature DB >> 20373997

Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins.

Jennifer L Nayak1, Katherine A Richards, Francisco A Chaves, Andrea J Sant.   

Abstract

Influenza is a contagious, acute respiratory disease that is a major cause of morbidity and mortality throughout the world. CD4 T cells play an important role in the immune response to this pathogen through the secretion of antiviral cytokines, and by providing help to CD8 T cells and B cells to promote the development of immunological memory and neutralizing antibody responses. Despite these well-defined roles in the anti-influenza response, our understanding of CD4 T-cell diversity and specificity remains limited. In the study reported here, overlapping peptides representing 5 different influenza viral proteins were used in EliSpot assays to enumerate and identify the specificity of anti-influenza CD4 T cells directly ex vivo following infection of mice with influenza virus, using two strains that express unrelated MHC class II molecules. These experiments evaluated whether the reactivity of CD4 T cells generally tracked with particular influenza proteins, or whether MHC preferences were the predominant factor dictating anti-CD4 T-cell specificity in the primary immune response. We made the unexpected discovery that the distribution of CD4 T-cell specificities for different influenza proteins varied significantly depending on the single class II molecule expressed in vivo. In SJL mice, the majority of epitopes were specific for the HA protein, while the NP protein dominated the response in C57BL/10 mice. Given the diversity of human MHC class II molecules, these findings have important implications for the ability to rationally design a vaccine that will generate a specific CD4 T-cell immune response that is effective across diverse human populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20373997      PMCID: PMC2883523          DOI: 10.1089/vim.2009.0099

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  67 in total

Review 1.  Immunodominance in CD4 T-cell responses: implications for immune responses to influenza virus and for vaccine design.

Authors:  Andrea J Sant; Francisco A Chaves; Frederick R Krafcik; Christopher A Lazarski; Paula Menges; Katherine Richards; Jason M Weaver
Journal:  Expert Rev Vaccines       Date:  2007-06       Impact factor: 5.217

Review 2.  Enhancing immunity through autophagy.

Authors:  Christian Münz
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

3.  CD4 T cell-mediated protection from lethal influenza: perforin and antibody-mediated mechanisms give a one-two punch.

Authors:  Deborah M Brown; Allison M Dilzer; Dana L Meents; Susan L Swain
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

Review 4.  Nuclear traffic of influenza virus proteins and ribonucleoprotein complexes.

Authors:  Sébastien Boulo; Hatice Akarsu; Rob W H Ruigrok; Florence Baudin
Journal:  Virus Res       Date:  2006-11-01       Impact factor: 3.303

Review 5.  Immunity to respiratory viruses.

Authors:  Jacob E Kohlmeier; David L Woodland
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 6.  A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A.

Authors:  Julie A McMurry; Bert E Johansson; Anne S De Groot
Journal:  Hum Vaccin       Date:  2007-10-14

Review 7.  The multifunctional NS1 protein of influenza A viruses.

Authors:  Benjamin G Hale; Richard E Randall; Juan Ortín; David Jackson
Journal:  J Gen Virol       Date:  2008-10       Impact factor: 3.891

8.  Selective CD4+ T cell help for antibody responses to a large viral pathogen: deterministic linkage of specificities.

Authors:  Alessandro Sette; Magdalini Moutaftsi; Juan Moyron-Quiroz; Megan M McCausland; D Huw Davies; Robert J Johnston; Bjoern Peters; Mohammed Rafii-El-Idrissi Benhnia; Julia Hoffmann; Hua-Poo Su; Kavita Singh; David N Garboczi; Steven Head; Howard Grey; Philip L Felgner; Shane Crotty
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

9.  Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2009-05-22       Impact factor: 17.586

10.  Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.

Authors:  Katherine A Richards; Francisco A Chaves; Frederick R Krafcik; David J Topham; Christopher A Lazarski; Andrea J Sant
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

View more
  34 in total

1.  The memory phase of the CD4 T-cell response to influenza virus infection maintains its diverse antigen specificity.

Authors:  Katherine A Richards; Francisco A Chaves; Andrea J Sant
Journal:  Immunology       Date:  2011-03-29       Impact factor: 7.397

2.  Loss in CD4 T-cell responses to multiple epitopes in influenza due to expression of one additional MHC class II molecule in the host.

Authors:  Jennifer L Nayak; Andrea J Sant
Journal:  Immunology       Date:  2012-08       Impact factor: 7.397

3.  Detection of site-specific positive Darwinian selection on pandemic influenza A/H1N1 virus genome: integrative approaches.

Authors:  Ramaiah Arunachalam
Journal:  Genetica       Date:  2013-03-26       Impact factor: 1.082

4.  Protein Vaccination Directs the CD4+ T Cell Response toward Shared Protective Epitopes That Can Be Recalled after Influenza Virus Infection.

Authors:  Ajitanuj Rattan; Katherine A Richards; Zackery A G Knowlden; Andrea J Sant
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

5.  Specificities of human CD4+ T cell responses to an inactivated flavivirus vaccine and infection: correlation with structure and epitope prediction.

Authors:  Julia Schwaiger; Judith H Aberle; Karin Stiasny; Bernhard Knapp; Wolfgang Schreiner; Ingrid Fae; Gottfried Fischer; Ondrej Scheinost; Vaclav Chmelik; Franz X Heinz
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

6.  CD4 T cell help is limiting and selective during the primary B cell response to influenza virus infection.

Authors:  Shabnam Alam; Zackery A G Knowlden; Mark Y Sangster; Andrea J Sant
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

7.  CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection.

Authors:  Anthony DiPiazza; Nathan Laniewski; Ajitanuj Rattan; David J Topham; Jim Miller; Andrea J Sant
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

8.  The utility and limitations of current Web-available algorithms to predict peptides recognized by CD4 T cells in response to pathogen infection.

Authors:  Francisco A Chaves; Alvin H Lee; Jennifer L Nayak; Katherine A Richards; Andrea J Sant
Journal:  J Immunol       Date:  2012-03-30       Impact factor: 5.422

9.  Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.

Authors:  Katherine A Richards; Francisco A Chaves; Shabnam Alam; Andrea J Sant
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

Review 10.  Memory CD4 T cell-mediated immunity against influenza A virus: more than a little helpful.

Authors:  K Kai McKinstry; Richard W Dutton; Susan L Swain; Tara M Strutt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-05-25       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.